Poorly Differentiated Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Poorly Differentiated Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer [Phase 1]
This document outlines an ongoing Phase 1 clinical trial evaluating AIC100 CAR T cells in anaplastic thyroid cancer and relapsed/refractory …
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: A Phase II Trial of Cabozantinib for the Treatment of Radioiodine (RAI)-Refractory Differentiated Thyroid Carcinoma (DTC) in the First-line Setting [Phase 2]
Phase II trial investigating cabozantinib as first-line treatment for radioiodine-refractory differentiated thyroid carcinoma (DTC).
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer [Phase 2]
Phase II trial of Sorafenib (Nexavar) in advanced thyroid cancers completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-12-21Clinical Trial Update: CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer [Phase 2]
Phase 2 trial update for CUDC-907 in metastatic and locally advanced thyroid cancer; study terminated with results posted in 2018.